These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 15206937)
1. Altered inactivation pathway of factor Va by activated protein C in the presence of heparin. Nicolaes GA; Sørensen KW; Friedrich U; Tans G; Rosing J; Autin L; Dahlbäck B; Villoutreix BO Eur J Biochem; 2004 Jul; 271(13):2724-36. PubMed ID: 15206937 [TBL] [Abstract][Full Text] [Related]
2. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin. Segers K; Dahlbäck B; Rosing J; Nicolaes GA J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572 [TBL] [Abstract][Full Text] [Related]
3. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S. Egan JO; Kalafatis M; Mann KG Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501 [TBL] [Abstract][Full Text] [Related]
4. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. Nicolaes GA; Tans G; Thomassen MC; Hemker HC; Pabinger I; Varadi K; Schwarz HP; Rosing J J Biol Chem; 1995 Sep; 270(36):21158-66. PubMed ID: 7673148 [TBL] [Abstract][Full Text] [Related]
5. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663 [TBL] [Abstract][Full Text] [Related]
6. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells. Hockin MF; Kalafatis M; Shatos M; Mann KG Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254 [TBL] [Abstract][Full Text] [Related]
7. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va. Tran S; Norstrøm E; Dahlbäck B J Biol Chem; 2008 Mar; 283(11):6648-55. PubMed ID: 18198180 [TBL] [Abstract][Full Text] [Related]
8. The autolysis loop of activated protein C interacts with factor Va and differentiates between the Arg506 and Arg306 cleavage sites. Gale AJ; Heeb MJ; Griffin JH Blood; 2000 Jul; 96(2):585-93. PubMed ID: 10887122 [TBL] [Abstract][Full Text] [Related]
9. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C. Gale AJ; Xu X; Pellequer JL; Getzoff ED; Griffin JH Protein Sci; 2002 Sep; 11(9):2091-101. PubMed ID: 12192065 [TBL] [Abstract][Full Text] [Related]
10. Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S. Tran S; Dahlbäck B J Thromb Haemost; 2010 Jan; 8(1):129-36. PubMed ID: 19874463 [TBL] [Abstract][Full Text] [Related]
11. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va. Van Walderveen MC; Berry LR; Atkinson HM; Chan AK Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984 [TBL] [Abstract][Full Text] [Related]
12. The mechanism of inactivation of human factor V and human factor Va by activated protein C. Kalafatis M; Rand MD; Mann KG J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361 [TBL] [Abstract][Full Text] [Related]
13. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C. Silveira JR; Kalafatis M; Tracy PB Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362 [TBL] [Abstract][Full Text] [Related]
14. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation. Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585 [TBL] [Abstract][Full Text] [Related]
15. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700 [TBL] [Abstract][Full Text] [Related]
16. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. Rosing J; Hoekema L; Nicolaes GA; Thomassen MC; Hemker HC; Varadi K; Schwarz HP; Tans G J Biol Chem; 1995 Nov; 270(46):27852-8. PubMed ID: 7499257 [TBL] [Abstract][Full Text] [Related]
17. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. Norstrøm EA; Steen M; Tran S; Dahlbäck B J Biol Chem; 2003 Jul; 278(27):24904-11. PubMed ID: 12707283 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the molecular defect in factor VR506Q. Kalafatis M; Bertina RM; Rand MD; Mann KG J Biol Chem; 1995 Feb; 270(8):4053-7. PubMed ID: 7876154 [TBL] [Abstract][Full Text] [Related]
19. C4b-binding protein protects coagulation factor Va from inactivation by activated protein C. van de Poel RH; Meijers JC; Rosing J; Tans G; Bouma BN Biochemistry; 2000 Nov; 39(47):14543-8. PubMed ID: 11087409 [TBL] [Abstract][Full Text] [Related]
20. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Heeb MJ; Kojima Y; Greengard JS; Griffin JH Blood; 1995 Jun; 85(12):3405-11. PubMed ID: 7780127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]